Kiss, B.,
Borbély, J.:
Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment.
Pharmaceutics. 15 (6), 1-18, (article identifier: 1761), 2023.
Kiss, B.,
Domonkos, D.,
Felföldi, J.:
New methods for structural development caused by open innovation in red biotechnology.
Apstract. 17 (1), 1-15, (article identifier: 12968), 2023.